Results of late-breaking developments from the POSEIDON Phase III trial revealed improved overall survival with a limited course of five cycles of tremelimumab added to durvalumab plus platinum chemotherapy.
This video will offer guidance on initiation protocols for venetoclax treatment in adult patients with chronic lymphocytic leukemia (CLL).
In this study, researchers determined that baseline geriatric measures and frailty and frailty were not associated with significant cognitive change among adult
Among patients with resected oral cavity squamous cell carcinoma, a new N-classification improved staging performance when compared against TNM-8-N.
At the Great Debates & Updates in Gastrointestinal Malignancies meeting, Nataliya Uboha, MD, PhD, University of Wisconsin, Carbone Cancer Center, Madison, Wi

<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->